100 related articles for article (PubMed ID: 15086746)
1. Tamoxifen-related uterine malignancies: carcinomas or sarcomas?
Delaloge S; Pautier P; Duvillard P
Int J Gynecol Cancer; 2004; 14(2):395. PubMed ID: 15086746
[No Abstract] [Full Text] [Related]
2. [Uterine sarcoma associated with tamoxifen use after breast cancer: Review of the pathogenesis].
Homer L; Muller M; Dupré PF; Lucas B; Pradier O
J Gynecol Obstet Biol Reprod (Paris); 2009 Dec; 38(8):629-33. PubMed ID: 19833452
[TBL] [Abstract][Full Text] [Related]
3. The risk of developing uterine sarcoma after tamoxifen use.
Lavie O; Barnett-Griness O; Narod SA; Rennert G
Int J Gynecol Cancer; 2008; 18(2):352-6. PubMed ID: 18334013
[TBL] [Abstract][Full Text] [Related]
4. Uterine sarcoma associated with tamoxifen use.
Wysowski DK; Honig SF; Beitz J
N Engl J Med; 2002 Jun; 346(23):1832-3. PubMed ID: 12050351
[No Abstract] [Full Text] [Related]
5. Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients.
Altaras MM; Aviram R; Beyth Y
Gynecol Oncol; 1991 Jun; 41(3):270. PubMed ID: 1869106
[No Abstract] [Full Text] [Related]
6. Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients.
Malfetano JH
Gynecol Oncol; 1990 Oct; 39(1):82-4. PubMed ID: 2132556
[TBL] [Abstract][Full Text] [Related]
7. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.
Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
Int J Gynecol Pathol; 2006 Apr; 25(2):173-5. PubMed ID: 16633068
[TBL] [Abstract][Full Text] [Related]
8. Association of tamoxifen and uterine sarcoma.
Wickerham DL; Fisher B; Wolmark N; Bryant J; Costantino J; Bernstein L; Runowicz CD
J Clin Oncol; 2002 Jun; 20(11):2758-60. PubMed ID: 12039943
[No Abstract] [Full Text] [Related]
9. Tamoxifen may increase risk of uterine sarcoma.
Gottlieb S
BMJ; 2002 Jul; 325(7354):7. PubMed ID: 12098716
[No Abstract] [Full Text] [Related]
10. Tamoxifen as risk factor for carcinoma of corpus uteri.
Hardell L
Lancet; 1988 Sep; 2(8610):563. PubMed ID: 2900934
[No Abstract] [Full Text] [Related]
11. Uterine pleomorphic rhabdomyosarcoma in a patient receiving tamoxifen therapy.
Okada DH; Rowland JB; Petrovic LM
Gynecol Oncol; 1999 Dec; 75(3):509-13. PubMed ID: 10600318
[TBL] [Abstract][Full Text] [Related]
12. [Uterine pathology in women with breast cancer treated with tamoxifen].
Carcangiu ML
Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
[No Abstract] [Full Text] [Related]
13. [Uterine sarcomas... or uterine carcinosarcomas?].
Leung F; Terzibachian JJ
J Gynecol Obstet Biol Reprod (Paris); 2010 Apr; 39(2):172. PubMed ID: 20079975
[No Abstract] [Full Text] [Related]
14. FDA issues warning about 'new' tamoxifen risk.
Twombly R
J Natl Cancer Inst; 2002 Aug; 94(15):1122. PubMed ID: 12165635
[No Abstract] [Full Text] [Related]
15. Uterine sarcoma after tamoxifen therapy for breast cancer.
Samuji M; O'Sullivan R; Shireen R
Ir Med J; 2013 Sep; 106(8):246. PubMed ID: 24282897
[TBL] [Abstract][Full Text] [Related]
16. Uterine sarcomas in breast cancer patients treated with tamoxifen.
Arenas M; Rovirosa A; Hernández V; Ordi J; Jorcano S; Mellado B; Biete A
Int J Gynecol Cancer; 2006; 16(2):861-5. PubMed ID: 16681774
[TBL] [Abstract][Full Text] [Related]
17. High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.
Sesti F; Patrizi L; Ermini B; Palmieri G; Orlandi A; Piccione E
Gynecol Obstet Invest; 2005; 60(2):117-20. PubMed ID: 15920338
[TBL] [Abstract][Full Text] [Related]
18. One step forward or one step back with tamoxifen?
Gelmon K
Lancet; 2000 Sep; 356(9233):868-9. PubMed ID: 11036885
[No Abstract] [Full Text] [Related]
19. Tamoxifen and breast cancer prevention: are we aware of the risks?
Mandeville R; Houde M
Cancer Prev Control; 1997; 1(1):66-72. PubMed ID: 9765729
[No Abstract] [Full Text] [Related]
20. Tamoxifen as a risk factor for endometrial cancer.
Hardell L
Cancer; 1990 Oct; 66(7):1661. PubMed ID: 2208019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
